Hypersensitivity, also known as allergy, refers to excessive or inappropriate immune responses that damage tissues. There are four main types of hypersensitivity reactions:
1. Type I are immediate hypersensitivity reactions mediated by IgE antibodies, as seen in allergic reactions like anaphylaxis.
2. Type II involve IgG and IgM antibodies binding to cells, leading to cell damage through phagocytosis or complement activation as seen in hemolytic disease of newborns.
3. Type III are immune complex-mediated reactions where antigen-antibody complexes deposit in tissues, activating complement and attracting inflammatory cells, seen in conditions like serum sickness.
4. Type IV are delayed hypersensitivity reactions mediated
A. There are three types of immunological disorders
1. Hypersensitivity
2. Autoimmune disease
3. Immunodeficiency
B. Hypersensitivity reactions to usually harmless substances are often called allergies or allergic reactions
Normally the immune system plays an important role in protecting the body from microorganisms and other foreign substances. If the activity of the immune system is excessive or overreactive, a hypersensitivity reaction develops. The consequences of a hypersensitivity reaction may be injury to the body or death.
Through this presentation you will be able to learn detailed information about hypersensitivity reactions, its type and clinical manifestation of all types of hypersensitivity reactions and related diseases.
Hypersensitivity (also called hypersensitivity reaction or intolerance) refers to undesirable reactions produced by the normal immune system, including allergies and autoimmunity.
A. There are three types of immunological disorders
1. Hypersensitivity
2. Autoimmune disease
3. Immunodeficiency
B. Hypersensitivity reactions to usually harmless substances are often called allergies or allergic reactions
Normally the immune system plays an important role in protecting the body from microorganisms and other foreign substances. If the activity of the immune system is excessive or overreactive, a hypersensitivity reaction develops. The consequences of a hypersensitivity reaction may be injury to the body or death.
Through this presentation you will be able to learn detailed information about hypersensitivity reactions, its type and clinical manifestation of all types of hypersensitivity reactions and related diseases.
Hypersensitivity (also called hypersensitivity reaction or intolerance) refers to undesirable reactions produced by the normal immune system, including allergies and autoimmunity.
Immediate or Type I hypersensitivity is a rapid immunological reaction occurring in a previously sensitized individual that is triggered by the binding of an antigen to IgE antibody on the surface of mast cells.
Type II Hypersensitivity-Antibody mediated cytotoxic HypersensitivityAnup Bajracharya
Type II Hypersensitivity is antibody-mediated immune reaction in which antibodies (IgG or IgM) are directed against cellular or extracellular matrix antigens with the resultant cellular destruction, functional loss, or damage to tissues.
The presentation includes an overview of hypersensitivity and type 1 hypersensitivity with certain pictures elaborating the mechanism. The presentation also talks about asthma very briefly as an example of type 1 hypersensitivity.
Concepts of hypersensivity should be well versed to all medical personnel to understand its implications. I have made it very simple to all readers to understand the same
Immediate or Type I hypersensitivity is a rapid immunological reaction occurring in a previously sensitized individual that is triggered by the binding of an antigen to IgE antibody on the surface of mast cells.
Type II Hypersensitivity-Antibody mediated cytotoxic HypersensitivityAnup Bajracharya
Type II Hypersensitivity is antibody-mediated immune reaction in which antibodies (IgG or IgM) are directed against cellular or extracellular matrix antigens with the resultant cellular destruction, functional loss, or damage to tissues.
The presentation includes an overview of hypersensitivity and type 1 hypersensitivity with certain pictures elaborating the mechanism. The presentation also talks about asthma very briefly as an example of type 1 hypersensitivity.
Concepts of hypersensivity should be well versed to all medical personnel to understand its implications. I have made it very simple to all readers to understand the same
hypersensitivity Undesirable reactions produced by the normal immune system. Hypersensitivity is an exaggerated immune response that results in tissue damage and is manifested in the individual on a second or subsequent contact with an antigen. Hypersensitivity reactions can be classified as either immediate or delayed. Obviously immediate reactions appear faster than delayed ones, but the main difference between them is the nature of the immune response to the antigen.
1. Type I Hypersensitivity:
Type I hypersensitive reactions are the commonest type among all types which is mainly induced by certain type of antigens i.e. allergens. Actually anaphylaxis means “opposite of protection” and is mediated by IgE antibodies through interaction with an allergen
PREPARED BY DR MUHAMMAD MUQEEM MANGI BASED ON GUYTON AND HALL 14TH EDITION WITH NET HELP, FOR THE MEDICAL STUDENTS OF FIRST YEAR MBBS ,DENTAL STUDENTS , DOCTORS OF PHYSIOTHERAPY AND PARAMEDICAL PERSONEL
Hypersensitivity reactions for Medical StudentsNCRIMS, Meerut
Hypersensitivity (animated) for MBBS Students
Hypersensitivity refers to undesirable (damaging, discomfort-producing and sometimes fatal) reactions produced by the normal immune system.
Hypersensitivity reactions require a pre-sensitized state of the host.
Four types of hypersensitivity
Type I – anaphylactic
Type II – cytotoxic
Type III – immune complex mediated
Type IV – contact, tuberculin and granulomatous
Anaphylaxis is defined as a life-threatening allergic reaction set in action by a wide range of antigens and involving multiple organ systems.
The true incidence is difficult to estimate, but in 1973 the Boston Collaborative Drug Surveillance Program reported six anaphylactic reactions and 0.87 deaths from anaphylaxis per 10,000 patients.
Reactions to insect stings alone are responsible for at least 50 deaths in the United States each year.
These figures reveal the importance of continued research into the biology of anaphylaxis along with developing new (and improving existing) therapies.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
2. History
The term allergy (most commonly used as synonym for
hypersensitivity) means an altered state of reactivity to
an antigen, it may include both protective as well as
injurious immune response) was originally coined by Von
Pirquet (1905).
3. Definition
Hypersensitivity refers to a condition in which immune
response results in excessive reactions leading to tissue
damage, disease or even death in the sensitized host.
Adverse clinical reaction to the antigen or,“when the
immune system does something bad to the host, i.e.
tissue damage”
Contcat Ag (allergen) T & B –cells (sensitization)
same Ag (allergen) Shocking dose Allergy
4.
5. Classification
Traditional classification
Feature Immediate type Delayed type
1. Onset and
duration
Appears and recedes
rapidly
Appears slowly in 24-72
hours and lasts longer
2. Immune response Antibody mediated Cell mediated
(T - lymphocytes)
3. Passive transfer Possible with serum Possible with lymphocyte
or transfer factor
3. Desensitisation Easy but short lived Difficult but long lasting
4. Induction Antigen or haptens,
by any route
By antigen injected
intradermally or by skin
contact
8. Type I Hypersensitivity
The term anaphylaxis (ana-wihout, phylaxis-
protection) was described by Richet (1902)
It is mediated by IgE antibodies.
Type I reaction occurs in two forms
i) The acute, potentially fatal, systemic
form called anaphylaxis.
ii) The recurrent non-fatal localised
form called atopy.
12. Chemical mediators
Two types :
1) Primary mediators : which are performed content of
mast cells and basophils granules.
a) Histamin
b) Serotonin (5HT)
c) Proteolytic enzyme
d) Eosinophil chemotactic factor of anaphylaxis (ECF-A)
13. Chemical mediators
2) Secondry mediators : which are newly
formed upon stimulation of mast cells, basophils
and other leucocytes.
a) Slow reacting substance of anaphylaxis
b) Prostaglandins and thromboxane
c) Platelet activating factor (PAF)
d) Other mediators
14. Features of Anaphylaxis
1. Anaphylaxis occurs within a few seconds to few
minutes following shocking dose of antigen.
2. IgE antibody is responsible.
3. It can be induced artificially by serum of sensitised
individual.
4. It is not release to heredity.
5. Tissue or organ which are affected in anaphylaxis
are called ‘target tissue’ or ‘shock organ’.
15.
16. Types of anaphylaxis
1. Anaphylaxis in vitro (schultz – Dale phenomenon).
2. Cutaneous anaphylaxis
3. Passive cutaneous anaphylaxis
17. Atopy
Atopy :
The term atopy (literally meaning out of place or
strangeness) was first introduced by Coca (1923).
To refer to naturally occuring familial hypersensitivities
of human being, typified by hay fever and asthma.
18. 1. Atopy runs in families. These individuals have tendency to
produce IgE Abs. In usually large amounts.
2. Reaction occur at the site of entry of the antigen,
inhalation of pollens affects lungs (bronchial asthma),
ingestion of fish, milk, eggs, drugs etc. (GI disorders)
and contact leads to local allergy (conjunctivitis).
3. It is IgE mediated hypersensitivity reaction.
4. Induction of atopy is difficult artificially because
atopens are poor antigen
Features of atopy
19. Mechanism of action of atopy
The atopens combine with the cell bound IgE Abs. fixed on the
surface of mast cells and the basophils and this antigen-antibody
complex stimulates these cells to release the mediators resulting
in clinical features of atopy.
Examples :
1. Food allergy : e.g. – eg, mushroom, shelfish.
2. Dust allergy : e.g. – pollens of ragweeds, grasses or trees, house
dust.
3. Drug allergy : e.g. – penicillin, sulphonamides.
20.
21. Prausnitz – kustner (PK) reaction :
Prausnitz – kustner (1921)
This was the original method for detecting atopic antibody.
Anaphylactoid reaction :
The reaction resembles anaphylactic shock clinically and is
provoked by intravenous injection of peptone, trypsin and some
others substances.
- It has no immunological basis.
.
24. Type II Hypersensitivity
Cytotoxic reaction
- Mediated by IgG (or rarely IgM) antibodies
directed against antigens on the surface of
the cells resulting in cell damage.
Antibodies bind to an antigen on the cell
surface and cause
1. Phagocytosis of the cell through opsonic or
immune adherent.
2. Cytotoxicity by natural killer (NK) cells.
3. Lysis through activation of complement
system.
26. Examples
1. Haemolytic Disease Newborn (HDN) or
Erythroblastosis. :
2. Drug reactions :
- Sedormid purpura is a classical example. It is not used
now a days.
- Other drugs : sulphonamid, quinidine.
28. Demonstration of type II reaction
Coombs test ( indirect antiglobulin test) is
usually positive.
29.
30.
31. Type III Hypersensitivity
Immune complex reaction
It is characterised by deposition of antigen –
antibody complexes in tissues, activation of
compliment and infiltration of
polymorphonuclear leucocytes leading to
tissue damage.
“Immune complex each required
Immune processes disease”
Soluble Ag/IgG or IgM
high titers of involved:
classical complement pathway
phagocytic cells
32. Type III is two typical type reaction :
i) Arthus reaction (localised) due to antibody
excess.
ii) Serum sickness (generalised) because of antigen
excess.
33. Arthus Reaction
- Arthus (1903)
- The arthus reaction can be passively transferred with sera
containing high titre of antibodies (IgG, IgM).
35. Serum sickness
- It is systemic form of type III hypersensitivity reaction.
- It appears following a single injection of high concentration of foreign
serum.
- Serum sickness is differs from other hypersensitivity in that a single
injection serves both as the sensitising and socking dose.
- Ag-Ab complex deposited on the endothelial lining of the
blood vessels various parts of the body complement
activation attract leucocyte leucocytes-platelets thrombi
formation reduced blood supply tissue necrosis
- Some important immune complex diseases are :
Post streptococcal glomerulonephritis, Endocarditis, Hepatitis B,
Dengue haemorrhagic fever and Malaria.
36. Sites of Complex Deposition
Site Outcome
Glomeruli Glomerulonephritis
Blood vessel wall Arteritis
Synovial membrane Arthritis
Skin Rash
Note: Ab responsible for immune complexes may be
generate at a site distant from the point of deposition.
37.
38.
39. Type IV Hypersensitivity
Delayed or cell mediated reaction
- It is mediated by sensitised T lymphocytes
- Two types Deayed hypersensitivity reaction.
1. Tuberculin (infection) type
2. Contact dermatitis type.
40.
41. Tuberculin (infection) type
Positive skin test does not indicate present infection but implies
that the person has been infected or immunised by the
microorganism in the past.
Some of these skin test include :
i. Lepromin test : It is positive in tuberculoid leprosy but negative
in lepromatous type of leprosy.
ii. Frei test : This test is positive in lymphogranuloma venereum
(LGV).
iii. Histplasmin test : It ispositive in histoplasmosis.
43. Contact dermatitis type
Delayed hypersensitivity sometime results from skin contact
with a variety of
1. chemicals – metals such as nickel and chromium.
2. Drugs such as penicillin or other antibiotics in ointments.
3. Simple chemicals like hair dyes, picryl chloride,
dinitrochlorobenzine.
4. Cosmetics.
5. Soaps
46. Patch test
This test is used to diagnose delayed
allergic reactions such as Contact
Dermatitis.
It involves taping traces of various
known contact allergens on the
skin and keeping them there for
48 hours.
49. Type V hypersensitivity
Type V - Cell surface receptors
Instead of killing or inhibition (not whole cell like
type II)
Leads to proliferation & differentiation
Ag-Ab complex enhances activity of affected cell.
Graves' disease excess production of thyroid
hormone